Yesterday the FDA issued a new guidance on conducting clinical trials. Click here to read the press release and guidance.
What this means for you:
With the recent updates and guidelines we have been monitoring for our industry, the FDA will necessarily issue guidance as medicines and treatments are being researched and tested. It is critical to follow Good Clinical Practice to avoid the warning letters that we have seen since the COVID-19 pandemic.
Learn more about our GCP thoughts and other solutions we have developed over the last two decades of helping our industry navigate clinical trials in a way that makes sense to develop processes designed to avoid regulatory compliance issues.
The Compliance Insight Team